- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Lupin secured tentative US FDA approval for its HIV drug, a generic version of Biktarvy®. The reference product had estimated annual US sales of USD 16,237 Cr, indicating a substantial market opportunity for Lupin.